Thrivent Financial for Lutherans’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41K Sell
37,116
-52,206
-58% -$57.7K ﹤0.01% 2421
2025
Q1
$71K Hold
89,322
﹤0.01% 2350
2024
Q4
$148K Sell
89,322
-36,048
-29% -$59.7K ﹤0.01% 2528
2024
Q3
$439K Buy
125,370
+24,804
+25% +$86.9K ﹤0.01% 2295
2024
Q2
$330K Buy
+100,566
New +$330K ﹤0.01% 2359